Porcine epidemic diarrhea virus resistant hyper-immune serum and preparation method thereof

A porcine epidemic diarrhea and hyperimmune serum technology is applied in antiviral agents, pharmaceutical formulas, antibody medical components, etc. It can solve the problems of weakened hyperimmune serum treatment effect, increased morbidity and mortality of infected pigs, etc., and achieves physical properties Good, high antibody titer, high cure rate effect

Active Publication Date: 2014-04-09
兆丰华生物科技(南京)有限公司 +3
View PDF3 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, once the clinically prevalent strain of porcine epidemic diarrhea virus mutates, the therapeutic effect ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Porcine epidemic diarrhea virus resistant hyper-immune serum and preparation method thereof
  • Porcine epidemic diarrhea virus resistant hyper-immune serum and preparation method thereof
  • Porcine epidemic diarrhea virus resistant hyper-immune serum and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1 Preparation of Porcine Epidemic Diarrhea Virus ZJ08 Strain Immunogen

[0022] Take an appropriate amount of porcine epidemic diarrhea-positive small intestine from a pig farm in Zhejiang, scrape the intestinal mucosa and contents, add PBS at a ratio of 1:5 (weight:volume), freeze and thaw repeatedly 3 times, centrifuge to take the supernatant, and filter it with a 0.22 μm membrane After filtration, trypsin with a final concentration of 20 μg / ml was added to the filtrate, and treated at 37° C. for 1.5 hours.

[0023] Inoculate monolayer Vero cells according to the conventional method, inoculate the virus at a ratio of 10%, absorb at 37°C for 1 hour, supplement the cell maintenance solution (containing 10 μg / ml trypsin), and incubate in a 37°C incubator. When passed to the 17th generation, obvious and stable CPE changes appeared, the cells shrank, the granules increased, and the piles were like bunches of grapes, and the cells were damaged and shed ( figure 1 )...

Embodiment 2

[0038] Example 2 Serum Preparation

[0039] 1) Immunization program

[0040] The first immunization: a total of 4ml intramuscular injection.

[0041] The second immunization: 14 days after the first immunization, the immunization dose is 8ml, and the injection is divided into two points.

[0042] The third immunization: 14 days after the second immunization, the immunization dose is 16ml, and injected in three points.

[0043] 2) blood collection

[0044]15-21 days after the last immunization, (the blood was collected once, the serum titer was measured by the neutralization test method, and then bled to death, with an interval of 3-4 days), the pigs were checked for health. No feed was given for the first 12 hours, but drinking water was not restricted. The butcher's knife and the skin where the knife enters are disinfected in advance, and the shallow basin containing blood is cleaned and then steam-sterilized. Sterile bloodletting.

[0045] 3) Serum separation and prepa...

Embodiment 3

[0048] Example 3 Determination of serum titer

[0049] Dilute the tested hyperimmune serum with DMEM at 1:2, 1:16, 1:32...1:512, and add an equivalent titer of 200 TCID to each dilution serum 50 / 0.1ml PEDV ZJ08 strain, neutralize at 37°C for 1 hour, inoculate 6 wells of a 96-well cell plate covered with Vero cell monolayer, 100 μl per well, and set 6 wells of non-neutralizing virus positive control cells and only inoculate cells Maintenance solution Negative control cells 6 wells, 37°C 5% CO 2 Cultivate in an incubator for 3 to 5 days, and observe CPE every day. There should be no cytopathic changes in the cell wells of the neutralization group and the negative control group, but the cells of the virus control group should appear cytopathic. The neutralization titer of the serum was taken as the highest dilution of the serum that could protect 50% of the cells from pathological changes. As can be seen from Table 1, the prepared anti-porcine epidemic diarrhea virus hyperimmu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses hyper-immune serum prepared by immunizing a hybridized pig with the age of 50-60 days by taking an inactivated vaccine of porcine epidemic diarrhea virus ZJ08 strain CGMCC No.7806 as an immunogen due to immunization for three times. The prepared hyper-immune serum is high in properties, high in specificity and high in safety and is not polluted by bacteria, moulds, mycoplasma and exogenous viruses, and the artificial infection cure rate is 100 percent. The neutralization titer of the serum is over 26, the serum is separately filled at the temperature of minus 70 DEG C, and the retention period is 12 months.

Description

technical field [0001] The invention relates to a preparation method of antiviral serum, in particular to anti-porcine epidemic diarrhea virus hyperimmune serum and a preparation method thereof. Background technique [0002] Porcine epidemic diarrhea (PED) is an acute, contagious viral intestinal infectious disease that causes diarrhea in pigs, characterized by watery diarrhea, vomiting, dehydration, and decreased appetite. PEDV can persist in pig herds, and pigs of all ages are susceptible. The morbidity rate of suckling piglets, shelf pigs and fattening pigs can reach 100%, especially severe with suckling piglets, and the case fatality rate reaches 100%. The disease is a viral disease, and there is currently no effective treatment. When pregnant sows are vaccinated, piglets can acquire resistance through passive immunity through colostrum, but with the disappearance or unevenness of maternal antibodies, the resistance of piglets gradually decreases or is different, and t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/215A61P31/14
Inventor 侯艳红王贵华赵亚荣于萍萍刘明明满坤陈翠云卢会英
Owner 兆丰华生物科技(南京)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products